ADAG
Adagene Inc. American Depositary Shares
Nasdaq · usd
Adagene Inc. American Depositary Shares (ADAG) trades at $2.49 (+3.32%) as of 4:10:04 PM EDT on Oct 26, 2026, -15.02% over the past month. Market cap is $161.82M, with 7.5 days to cover in short interest.
Stock performance
How Adagene Inc. American Depositary Shares (ADAG) stock has performed from one day to one year, with its 52-week range.
- 1D
- +3.32%
- 1W
- +8.73%
- 1M
- -15.02%
- YTD
- +31.75%
- 1Y
- +34.96%
- 52-wk range
- $1.30 – $4.85
Key statistics
Today's trading snapshot for ADAG: day range, open, previous close, volume and market cap.
- Day range
- $2.34 – $2.55
- Open
- $2.42
- Prev close
- $2.41
- Volume
- 91.2K
- Market cap
- $161.82M
- Shares out
- 67.14M
ADAG short interest
How heavily ADAG is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.5
- Short interest
- 2.11M
- Avg volume
- 282.9K
As of · reported to FINRA twice monthly.
ADAG news
The latest news and headlines about Adagene Inc. American Depositary Shares (ADAG).
- Adagene Reports Full Year 2025 Financial Results and Provides Corporate UpdatepositiveGlobeNewswire Inc.· Apr 1, 2026
- Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® TechnologypositiveGlobeNewswire Inc.· Nov 13, 2025
- Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal CancerpositiveGlobeNewswire Inc.· Oct 31, 2025
- Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, ChinapositiveGlobeNewswire Inc.· Sep 5, 2025
- Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDApositiveGlobeNewswire Inc.· Jul 15, 2025
Frequently asked questions
What is the Adagene Inc. American Depositary Shares (ADAG) stock price today?
Adagene Inc. American Depositary Shares (ADAG) is trading at $2.49 (+3.32% on the day) as of 4:10:04 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Adagene Inc. American Depositary Shares?
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies.
What is the short interest in ADAG?
As of Sep 30, 2026, ADAG has 2.11M shares short and 7.5 days to cover.
What exchange is ADAG listed on?
Adagene Inc. American Depositary Shares (ADAG) trades on Nasdaq in USD.
Build with AI
Build an analysis of ADAG with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ADAG analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.